Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of IUI and Pregnancy Outcome in Unexplained Infertility
NCT03920514Phase 4Unknown
- Sponsor
- Sohag University
- Start
- Apr 2019
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of human chorionic gonadotropin in Unexplained infertility and infertility (4 arms), sponsored by Sohag University. Primary endpoint: Number of pregnant women at 14 days. Status: unknown.
02
Drugs
human chorionic gonadotropin
03
Conditions
Unexplained infertilityinfertility
Beyond the preview
Go deeper on NCT03920514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03920514.